General Information of Drug Formulation (ID: F15983)

Formulation Name
Ondansetron 4 mg tablet
Company
American Health Packaging; Aurobindo Pharma; Preferred Pharamaceuticals; Proficient Rx; Unit Dose Services
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Ondansetron DMOTQ1I Chemotherapy-induced nausea MD90 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Beta-D-lactose E00099 6134 Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Triacetin E00080 5541 Humectant; Plasticizing agent; Solvent